Avascular necrosis of the jaws: risk factors in metastatic cancer patients von Tarassoff, Peter, Csermak, Katalin

Volltext

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer von Rothenberg, M. L., Moore, M. J., Cripps, M. C., Andersen, J. S., Portenoy, R. K., Burriss, H. A., Green, M. R., Tarassoff, P. G., Brown, T. D., Casper, E. S., Storniolo, A.-M., Von Hoff, D. D.

Volltext

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial von BURRIS, H. A, MOORE, M. J, NELSON, R, DORR, F. A, STEPHENS, C. D, VON HOFF, D. D, ANDERSEN, J, GREEN, M. R, ROTHENBERG, M. L, MODIANO, M. R, CRIPPS, M. C, PORTENOY, R. K, STORNIOLO, A. M, TARASSOFF, P

Volltext

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas von CASPER, E. S, GREEN, M. R, KELSEN, D. P, HEELAN, R. T, BROWN, T. D, FLOMBAUM, C. D, TROCHANOWSKI, B, TARASSOFF, P. G

Volltext

Osteonecrosis of the Jaw and Bisphosphonates von Durie, Brian G M, Katz, Michael, Crowley, John

Volltext

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine von Abbruzzese, J L, Grunewald, R, Weeks, E A, Gravel, D, Adams, T, Nowak, B, Mineishi, S, Tarassoff, P, Satterlee, W, Raber, M N

Volltext

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer von FOSSELLA, F. V, LIPPMAN, S. M, WAUN KI HONG, SHIN, D. M, TARASSOFF, P, CALAYAG-JUNG, M, PEREZ-SOLER, R, JIN SOO LEE, MURPHY, W. K, GLISSON, B, RIVERA, E

Volltext

Therapeutic Vaccines for Prostate Cancer von Tarassoff, Christopher P., Arlen, Philip M., Gulley, James L.

Volltext

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study von GRUNEWALD, R, KANTARJIAN, H, DU, M, FAUCHER, K, TARASSOFF, P, PLUNKETT, W

Volltext

Phase II trial of gemcitabine in patients with advanced gastric cancer von Christman, Kathy, Kelsen, David, Saltz, Leonard, Tarassoff, Peter G.

Volltext

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days von O'Rourke, T.J., Brown, T.D., Havlin, K., Kuhn, J.G., Craig, J.B., Burris, H.A., Satterlee, W.G., Tarassoff, P.G., Von Hoff, D.D.

Volltext

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine von GRUNWALD, R, ABBRUZZESE, J. L, TARASSOFF, P, PLUNKETT, W

Volltext

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (gemcitabine) administration in leukemia von GRUNEWALD, R, KANTARJIAN, H, KEATING, M. J, ABBRUZZESE, J, TARASSOFF, P, PLUNKETT, W

Volltext

Pyrometallurgy von Tarassoff, P.

Volltext

950 Dyspnoea with gemcitabine is commonly seen, often disease related, transient, and rarely severe von Nelson, R., Tarassoff, P.

Volltext

Pyridoxal phosphate as an antisickling agent in vitro von KARK, J. A, TARASSOFF, P. G, BONGIOVANNI, R, HICKS, C. U, JENKINS, E

Volltext

Successful renal transplantation for epstein syndrome von Alving, Barbara M., Tarassoff, Peter G., Moore, Jack, Leissenger, Cindy A., Fernandez‐Bueno, C.

Volltext

Inhibition of erythrocyte sickling in vitro by pyridoxal von Kark, J A, Kale, M P, Tarassoff, P G, Woods, M, Lessin, L S

Volltext

Advances in Pyrometallurgy — 1983 von Mackey, P. J., Tarassoff, P.

Volltext

PYROMETALLURGY, ARTICLE FROM ANNUAL REVIEW OF EXTRACTIVE AND PROCESS METALLURGY von TARASSOFF, P

Volltext